The Hidden Relationship Between Loneliness and Substance Use Disorders

Key Takeaways

  • Loneliness and substance use move in a bidirectional loop, with depression and anxiety mediating the pathway, so treating any single piece in isolation tends to leave the pattern intact.
  • Loneliness is linked with more mental health crises and emergency visits among people with substance use disorders, which makes social connection a meaningful part of treatment rather than an optional extra.
  • Across life stages, isolation and substance use can reinforce each other—from adolescents pulling away as use increases to older adults using substances while increasingly cut off from support.
  • Integrated care that screens for connection, holds overlapping conditions together, uses group work as corrective social experience, and maintains continuity across levels of care gives recovery something more durable to stand on.

When Was the Last Time You Felt Truly Known

Take a moment with this one. When was the last time someone looked at you and you felt genuinely seen, not just noticed?

If that question landed a little heavy, you are not the only one sitting with it. A lot of people who reach out to us can name the last drink or the last pill more easily than they can name the last time they felt close to another human being. That gap is not a character flaw. It is a clue.

Loneliness and substance use tend to travel together, and the research is clear that they shape each other in both directions. One does not simply cause the other. They feed each other quietly, often for years, tangled up with depression, anxiety, trauma, and sometimes disordered eating. So when you or someone you love keeps returning to a drink, a substance, or a behavior that eases the ache for a few hours, there is usually more going on underneath than willpower can explain.

This article is written for you if you are wondering whether that ache has a name, and whether care that treats both the loneliness and the substance use actually exists. It does. And understanding how they connect is the first step toward finding it.

Loneliness Is a Clinical Variable, Not a Mood

What the Research Actually Measures

Most people hear the word loneliness and picture a feeling, something that comes and goes with a bad week. Researchers who study this in the context of substance use treat it differently. They measure it with validated scales, track it over time, and compare it against clinical outcomes the same way they would track a lab value or a symptom score.

A structured research review of 22 studies on loneliness in people with substance use problems found it is prevalent, experienced as distressing, and tied to poor mental and physical health, substance use severity, relationship quality, and the sting of being treated badly by others. That is not a mood. That is a variable that moves with the illness.

The distinction matters for you or your loved one because it changes what care should be watching. When a clinician screens for depression and craving but never asks how connected you feel, they are missing a signal that predicts how the next month is likely to go. Naming loneliness in the chart, tracking it week to week, and folding it into the treatment plan is what separates integrated care from care that treats symptoms in isolation.

The Bidirectional Loop No One Talks About

The story you have probably heard goes one direction. Someone feels lonely, so they drink or use, and eventually they get hooked. That version is not wrong, but it is only half the picture.

The other half is that substance use itself deepens isolation. Relationships strain. Shame builds. The people you used to feel safe with start to feel far away, and the substance starts to feel like the only thing that shows up on time. The structured research review of 22 studies makes this bidirectional pattern explicit, linking loneliness to both the severity of use and the experience of being treated poorly by others, which then reinforces the withdrawal.

Depression and anxiety sit in the middle of this loop, doing quiet work. Research on loneliness during collective traumatic events found that people with higher loneliness scores reported increased alcohol, marijuana, opioid, and illicit drug use, and that this relationship was partly mediated by depression and anxiety. In plain language, loneliness fuels the mood symptoms that fuel the use, and the use fuels the isolation that started the whole thing.

That is why targeting only the drinking, or only the depression, or only the loneliness so often leaves the loop intact. You have to interrupt it in more than one place at once.

How the Loop Looks Different Across Life Stages

Adolescents: When Substance Use and Loneliness Grow Together

If you are a parent watching your teenager pull away, the story you are seeing is not just moody withdrawal. It is often a real feedback loop starting to lock in.

A Centers for Disease Control and Prevention (CDC)-hosted analysis of alcohol and cannabis use in adolescents and young adults looked at this both within individuals over time and between different people. The pattern was consistent. Youth with more severe alcohol and cannabis use experienced greater loneliness over time, meaning the two do not just correlate at a single snapshot. They co-evolve.

Picture this in a real week. A ninth grader who used to text friends constantly starts vaping alone after school. A few months later, the group chats have gone quiet, the weekend plans are thinner, and the vaping has moved from occasional to daily. Neither the loneliness nor the use showed up first in a dramatic way. They took turns feeding each other.

The clinical read for families is important. Waiting for the substance use to reach a crisis before addressing the isolation misses the window when both are still moving together. Adolescent care that treats the two as one connected picture, rather than as a discipline problem plus a mood problem, tends to interrupt the loop earlier.

Young Adults: The Pandemic Cohort and What It Revealed

The early months of COVID-19 gave researchers something they rarely get. A natural experiment in what happens when a whole cohort loses its normal social scaffolding almost overnight.

A 2020 research of U.S. young adults during that period reported striking numbers. 49% scored above the threshold for high loneliness on the UCLA scale, 80% met criteria for depression, 61% for anxiety, and 30% reported harmful drinking. Loneliness in that sample was associated with higher mental health symptoms overall.

Read those percentages carefully. They are not four separate problems sitting next to each other. They are one cluster, with loneliness threaded through the rest. A young adult who was drinking heavily during that stretch was very likely also depressed, anxious, and lonely at the same time. Pulling one thread does not untangle the knot.

A longitudinal study that followed people from before the pandemic through spring 2021 added a second layer. Those who stayed in higher loneliness trajectories had greater odds of past-month cannabis use compared with people on low-loneliness paths. The same study found that pre-pandemic social support predicted lower odds of ending up on a high-loneliness trajectory in the first place.

The scope of these findings matters. The research captured young adults during an acute collective stressor, and the longitudinal work focused on how loneliness paths tracked over roughly a year of upheaval. Even with those limits, the takeaway holds for young adults now. If you are in your twenties, using regularly, and quietly feeling like no one really knows you, you are not an outlier. You are inside a well-documented pattern, and the care that fits your situation has to address all of it at once.

Midlife and Older Adults: A Quieter, More Dangerous Pattern

For adults over 50, the loop tends to move slower and draw less attention, which is part of what makes it so risky.

A 2026 study of nationally representative data on adults aged 50 and older asked whether substance use tracked with loneliness in this age group, and by how much. After adjusting for demographics, health, and social variables, adults 50 and older who reported using at least one substance were 17% more likely to report feeling lonely always or usually compared with non-users. The substances in the analysis included alcohol, tobacco, and cannabis, the ones most likely to be hiding in plain sight at this life stage.

The picture gets sharper when you add opioids to the frame. A 2025 national survey study found that severe social withdrawal in older adults was associated with 1.59 to 2.1 times higher odds of past-year prescription opioid misuse, with predicted misuse probabilities of about 6% among those with severe withdrawal versus 1% among those without, independent of mental and physical health. Social withdrawal was doing its own work in that data, not just standing in for depression or pain.

Consider what this looks like in a family. A parent in their sixties has a nightly bourbon that has slowly grown, still fills prescriptions on time, and rarely picks up the phone anymore. Nothing in that picture screams crisis. But the research is telling you the isolation and the use are moving together, and the risk of a bad outcome is climbing quietly.

People in Opioid Treatment: Craving Meets Isolation

For anyone in medication-based opioid treatment, or thinking about it, loneliness deserves its own line on the treatment plan.

A 2023 article on people receiving medication for opioid use disorder in an Appalachian sample reviewed the broader literature and made the connection plain. Loneliness in this population is directly related to substance abuse and drug craving, and prior evidence links it to increased likelihood of illicit opioid use and a return to substance use.

The same study offered a useful nuance. In that specific cohort, loneliness did not predict treatment retention, which suggests it hits some outcomes harder than others. Craving and return to use appear more sensitive to isolation than showing up for the next appointment does.

What that means practically is this. Staying in a medication program is a win, and it is not the whole job. If cravings keep spiking and the days between meetings feel empty, the missing piece is often relational, not pharmacological. Group work, peer connection, and consented family involvement give the treatment something to hold onto between doses. That is why we build those layers into care rather than treating medication management as a standalone fix.

Why Treating One Condition at a Time Keeps People Cycling Back

Most treatment histories we read tell a version of the same story. Someone got help for the drinking. Later, someone else treated the depression. A third clinician, years down the line, finally asked about the trauma. Each round did some good, and yet the substance use kept coming back.

The research explains why. The loneliness-to-substance-use pathway is partly mediated by depression and anxiety, which means the mood symptoms are doing real work in the middle of the loop. Treat the drinking without touching the depression, and the mood dip that used to trigger a drink is still there. Treat the depression without touching the isolation, and the empty evenings that fed the mood are still there. The unaddressed pieces keep the pattern warm.

Add eating disorders into the picture and the case for integrated treatment gets stronger. A person restricting food, drinking to numb, and quietly cutting off friends is not living three separate illnesses. They are living one interconnected experience, and asking them to break it into three referrals often means none of the three sticks.

This is the clinical reason we do not track patients by a single primary diagnosis at SunCloud Health. When someone comes in with substance use, disordered eating, a mood disorder, and unresolved trauma, we build one plan that holds all of it, with the same team watching how the pieces move together. That is a different job than sequencing four separate programs, and the loop we described earlier is the reason it has to be done that way.

What Integrated Care Looks Like in Practice

Group Work as a Corrective Social Experience

If loneliness is doing clinical work, then group therapy is doing clinical work back. Not the version where everyone sits in a circle and takes turns talking at the floor. The version where you actually feel, in real time, that another person in the room gets what you just said.

That distinction matters because the structured research review of loneliness in people with substance use problems found that relationship quality and the experience of being treated poorly by others are tied to how severe the illness gets. If bad social experiences fed the loop, only corrective social experiences can start to loosen it.

In our process groups, we build that on purpose. Experiential exercises give people something to do together, not just talk about, so the connection lands in the body rather than staying in the head. A patient who has spent years feeling like an outsider gets a lived rehearsal of being included, week after week. That is different work than a coping-skills lecture, and it is one of the reasons group is not an add-on for us. It is where a lot of the healing actually happens.

Family Involvement, With Consent

Family work can move outcomes, and it also has to be your call.

The research is clear that supportive relationships buffer against high-loneliness paths and better outcomes over time. Bringing the people closest to you into some part of treatment, with education, coaching, and space to talk through what recovery actually asks of them, gives that support somewhere to grow.

If your loved ones have been part of the pain, that is real, and we take it seriously. If they are part of who you want to heal alongside, our Family Members and Loved Ones program is built to hold that carefully.

Continuity Across Levels of Care

One of the quiet reasons loneliness reasserts itself after treatment is a handoff that never quite happens. Residential ends, the calendar empties, and the people who knew your story last week are suddenly a phone number you are not sure you should call.

We built our continuum to close that gap. The same clinical team and philosophy carry through residential, partial hospitalization, intensive outpatient, and virtual evening intensive outpatient program (IOP), so the relationships you build early do not reset every time your level of care steps down. Psychiatry stays involved throughout, with most patients seen weekly by one of our psychiatrists across levels, which matters when depression or anxiety is doing mediating work in the loop.

Alumni check-ins, ongoing group options, and community partnerships extend that thread past discharge. None of it is fancy. It is a deliberate answer to a specific problem, which is that continuity of connection is part of what treats the illness, not a nice add-on after the illness is treated.

What Protects People, Before and After Treatment

If loneliness and substance use feed each other, then connection is not a nice extra at the end of treatment. It is part of the medicine.

The longitudinal work on loneliness trajectories makes this concrete. People who had stronger social support before a period of major stress were significantly less likely to end up on a high-loneliness path through it, which in turn lowered their odds of the substance use patterns that traveled with those paths. Support built in advance changed what the same stressor did to a person.

That points to a few things worth protecting, on purpose.

  • One or two relationships where you can be honest without editing yourself.
  • A weekly rhythm that puts you in the same room as the same people, whether that is a group, a meeting, or a family dinner.
  • Skills that let you sit with a hard feeling instead of racing to shut it off, which is one reason mindfulness-based work shows up alongside loneliness in opioid recovery research.

After treatment, the same principles hold. Stay in a group. Keep the psychiatry appointment. Say yes to the alumni check-in even when you feel fine, because feeling fine is exactly when the loop starts quietly rebuilding. You do not have to do this alone, and the evidence says you should not try.

Feeling Alone in Recovery? Talk With Us

Connect directly for confidential guidance on addressing loneliness and substance use concerns.

Important clinical context: Loneliness is associated with substance-use risk and poorer recovery outcomes, but association does not mean that loneliness alone causes addiction. Mental health symptoms, trauma, environment, access to support, and patterns of substance use all need to be assessed together.

Frequently Asked Questions

Can loneliness actually cause addiction, or is it the other way around?

Both, and that is the honest answer. Loneliness raises the risk that someone starts and escalates substance use, and substance use deepens the isolation through shame, strained relationships, and stigma. The two shape each other over time, which is why pulling on just one thread rarely loosens the knot.

How do I know if my loved one’s substance use is tied to loneliness rather than something else?

Watch for the pattern, not a single moment. Fewer calls returned, canceled plans, more time alone with the substance, and a shrinking circle of people who really know them. In substance-dependent adults, loneliness shows up across emotional, social, and family dimensions. If several of those pieces have shifted together, isolation is likely part of the picture.

Why does treatment that only targets the substance use often fail?

Because the underlying loop stays intact. Depression and anxiety partly mediate the link between loneliness and substance use, so treating the drinking without addressing the mood or the isolation leaves the same triggers waiting. Care that holds the co-occurring pieces together, rather than passing them between separate providers, gives recovery something more durable to stand on.

What does treatment that addresses both loneliness and substance use actually involve?

It looks like screening for how connected you feel, not just how much you use. Psychiatry and therapy work in coordination, group sessions create real corrective social experiences, and, with your consent, family work adds support at home. Continuity across residential, partial hospitalization program (PHP), IOP, and virtual IOP keeps the relationships you build from resetting every time your level of care changes.

Is loneliness a bigger risk factor for certain age groups?

The loop shows up across the lifespan, but it wears different clothes. In older adults, social withdrawal is tied to substantially higher odds of prescription opioid misuse independent of mental and physical health. In adolescents and young adults, substance use severity and loneliness rise together over time. Different age, same underlying pattern.

How can family members help without making things worse?

Stay present, stay curious, and let your loved one lead on treatment decisions. Family involvement at SunCloud Health happens only with the patient’s consent, and we strongly encourage it because supportive relationships buffer against high-loneliness paths. Learn what recovery actually asks of you, keep showing up, and let the clinical team guide the harder conversations.

Sources

  • Understanding the Association Between Substance Use and Loneliness Among Midlife and Older Adults. View source
  • Loneliness among people with substance use problems. View source
  • Trajectories of loneliness during COVID-19 pandemic and associations with psychological distress and substance use. View source
  • Does COVID-19 affect mental health and substance use in young adults?. View source
  • Emotional and Social Loneliness in Individuals With Substance Dependence. View source
  • Association of Loneliness and Mindfulness in Substance Use Disorder Populations. View source
-Our Research Team-
Timothy D. Brewerton, MD, DLFAPA, FAED, DFAACAP, CEDS-S
Professor Emeritus of Psychiatry and Behavioral Sciences
Dr. Christopher Womack
Medical Director, Child and Adolescent Psychiatry
Dr. Christopher Womack joins SunCloud as our Medical Director, Child and Adolescent Psychiatry. Dr. Womack is board certified in Adult as well as Child and Adolescent Psychiatry, attending the University of Chicago Pritzker School of Medicine. Adult psychiatry residency and child fellowship training were completed at the University of Chicago Medical Center. Dr. Womack’s treatment  philosophy hinges on strength based, evidence informed care, where collaboration is central to guiding individualized treatment.  He has experience caring for children and teens from varied backgrounds, appreciating the importance of how identity can inform treatment. Favorite pastimes are cooking new recipes and exploring Chicago’s rich cultural diversity through its neighborhood and fine dining experiences.
Elizabeth E. Sita, MD
Medical Director of Adult Services

Dr. Elizabeth E. Sita, MD, is a Board Certified psychiatrist specializing in the care of patients with eating disorders. She completed her undergraduate training at the University of Chicago and graduated with Highest Honors. She then earned her medical degree at Northwestern University Feinberg School of Medicine and was recognized with the Chairman’s Award for Excellence in Psychiatry. She subsequently completed residency with the Department of Psychiatry and Behavioral Sciences at McGaw Medical Center of Northwestern University, where she was elected Chief Resident and received the Resident Psychiatrist Leadership & Service Award.

Upon completing her training, Dr. Sita joined the staff atAscension Alexian Brothers Behavioral Health Hospital Hospital, where she served as Assistant Medical Director of the Center for Eating Disorders and Director of Transcranial Magnetic Stimulation Services before transitioning to lead the new inpatient eating disorder unit as Medical Director of Eating Disorder Services at Ascension Saint Joseph Hospital – Chicago. In these roles, she has cared for a multitude of adolescents and adults struggling with anorexia nervosa, bulimia nervosa, binge eating disorder, and other eating disorders as well as severe, cooccurring mood, trauma, personality, and substance use disorders.

Dr. Sita has been recognized throughout her training and practice for a commitment to excellence in patient care and for her ability to engage patients in their most challenging moments. Her passions include the care of treatment-resistant eating and mood disorders as well as questions of medical capacity and end-of-life decision making.

She believes that, first and foremost, human connection is key to mental health and well-being and strives to share this philosophy in each and every patient encounter. She is excited to bring her expertise to SunCloud Health as the Medical Director of Adult Services!

 

VIDEO: Meet Elizabeth E. Sita, MD, Medical Director of Adult Services

 

Lacey Lemke, PsyD
Assistant Vice President of Clinical Services

Dr. Lacey Lemke (she/her) is a licensed clinical health psychologist with specialized expertise in the treatment of eating disorders and the practice of medical and health psychology. She completed her doctoral training in clinical psychology with a Primary Care emphasis at the Adler School of Professional Psychology. Dr. Lemke went on to complete both her predoctoral clinical internship and postdoctoral fellowship through Ascension Health, where she gained advanced training working with individuals experiencing eating disorders and self-injurious behaviors, as well as within pediatric subspecialty settings including endocrinology, neurology, and adolescent medicine.

Dr. Lemke is deeply committed to providing evidence-based, compassionate care and collaborates closely with interdisciplinary teams to ensure comprehensive treatment. Her professional mission is to support patients in achieving their fullest potential by guiding them to the most appropriate level of care and empowering them to make meaningful, sustainable progress toward improved health and well-being.

VIDEO: 2. Meet Lacey Lemke, PsyD.